BNIP3L in myelodysplastic syndromes and acute myeloid leukemia: impact on disease outcome and cellular response to decitabine | Aplastic Anemia and MDS International Foundation

BNIP3L in myelodysplastic syndromes and acute myeloid leukemia: impact on disease outcome and cellular response to decitabine

Journal Title: 
Haematologica
Primary Author: 
Lazarini M
Author(s): 
Lazarini M, Machado-Neto JA, Duarte AD, Pericole FV, Vieira KP, Niemann FS, Alvarez M, Traina F, Saad ST
Original Publication Date: 
Tuesday, November 1, 2016

mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-bidi-font-family:
"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:EN-US;
mso-bidi-language:AR-SA">No abstract available.

Bone Marrow Diseases: